Nifty
Sensex
:
:
26046.95
85267.66
148.40 (0.57%)
449.53 (0.53%)

Pharmaceuticals & Drugs

Rating :
58/99

BSE: 544067 | NSE: INNOVACAP

721.40
12-Dec-2025
  • Open
  • High
  • Low
  • Previous Close
  •  724
  •  738
  •  706.75
  •  724.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  31617
  •  22705055.95
  •  1260
  •  660

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,114.19
  • 33.06
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,391.20
  • N/A
  • 4.03

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.90%
  • 1.06%
  • 27.35%
  • FII
  • DII
  • Others
  • 0.07%
  • 12.65%
  • 7.97%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 24.81
  • 10.32

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 27.86
  • 10.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 30.03
  • 23.59

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Earnings Forecasts:

(Updated: 13-12-2025)
Description
2024
2025
2026
2027
Adj EPS
22.41
27.63
37.58
47.68
P/E Ratio
32.19
26.11
19.20
15.13
Revenue
1243.68
1630.9
1984.2
2430.85
EBITDA
186.15
248
315.7
390.75
Net Income
128.26
158
215.15
272.9
ROA
8.84
8.17
9.72
10.97
P/B Ratio
4.30
3.65
3.01
2.43
ROE
14.33
15.22
17.49
18.5
FCFF
-106.51
184.6
176.5
255.9
FCFF Yield
-2.37
4.1
3.92
5.68
Net Debt
269.95
100
-50
-243
BVPS
167.66
197.9
239.5
296.9

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Net Sales
380.38
318.20
19.54%
351.54
294.27
19.46%
314.74
262.63
19.84%
316.46
302.49
4.62%
Expenses
328.52
268.47
22.37%
299.44
252.09
18.78%
267.06
224.56
18.93%
269.90
257.89
4.66%
EBITDA
51.86
49.73
4.28%
52.10
42.18
23.52%
47.69
38.08
25.24%
46.56
44.60
4.39%
EBIDTM
13.63%
15.63%
14.82%
14.33%
15.15%
14.50%
14.71%
14.74%
Other Income
4.19
2.22
88.74%
4.48
2.12
111.32%
3.38
5.69
-40.60%
4.33
2.34
85.04%
Interest
5.50
0.15
3,566.67%
2.86
0.14
1,942.86%
1.95
0.81
140.74%
0.17
6.80
-97.50%
Depreciation
11.32
4.99
126.85%
11.04
4.85
127.63%
9.80
3.41
187.39%
5.13
4.93
4.06%
PBT
39.23
46.81
-16.19%
42.68
39.31
8.57%
39.31
39.55
-0.61%
45.59
35.20
29.52%
Tax
9.57
11.80
-18.90%
11.66
9.83
18.62%
9.74
10.82
-9.98%
11.38
10.07
13.01%
PAT
29.67
35.00
-15.23%
31.01
29.48
5.19%
29.57
28.72
2.96%
34.20
25.13
36.09%
PATM
7.80%
11.00%
8.82%
10.02%
9.40%
10.94%
10.81%
8.31%
EPS
5.18
6.12
-15.36%
5.42
5.15
5.24%
5.17
5.02
2.99%
5.98
4.39
36.22%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
1,363.12
1,243.68
1,081.31
926.38
800.53
410.66
Net Sales Growth
15.76%
15.02%
16.72%
15.72%
94.94%
 
Cost Of Goods Sold
872.27
639.36
579.35
552.63
529.46
273.02
Gross Profit
490.85
604.32
501.96
373.76
271.07
137.65
GP Margin
36.01%
48.59%
46.42%
40.35%
33.86%
33.52%
Total Expenditure
1,164.92
1,057.52
926.85
812.73
704.51
356.18
Power & Fuel Cost
-
27.14
20.39
9.51
7.91
5.48
% Of Sales
-
2.18%
1.89%
1.03%
0.99%
1.33%
Employee Cost
-
116.78
90.66
54.80
40.46
22.33
% Of Sales
-
9.39%
8.38%
5.92%
5.05%
5.44%
Manufacturing Exp.
-
207.40
177.68
152.24
100.72
43.28
% Of Sales
-
16.68%
16.43%
16.43%
12.58%
10.54%
General & Admin Exp.
-
36.83
32.63
23.39
15.22
8.59
% Of Sales
-
2.96%
3.02%
2.52%
1.90%
2.09%
Selling & Distn. Exp.
-
18.38
15.67
14.24
6.93
2.18
% Of Sales
-
1.48%
1.45%
1.54%
0.87%
0.53%
Miscellaneous Exp.
-
11.63
10.47
5.93
3.81
1.30
% Of Sales
-
0.94%
0.97%
0.64%
0.48%
0.32%
EBITDA
198.21
186.16
154.46
113.65
96.02
54.48
EBITDA Margin
14.54%
14.97%
14.28%
12.27%
11.99%
13.27%
Other Income
16.38
12.04
12.49
9.20
2.88
1.37
Interest
10.48
2.40
21.46
19.97
5.68
3.93
Depreciation
37.29
24.78
15.96
11.08
7.50
5.59
PBT
166.81
171.02
129.53
91.80
85.72
46.34
Tax
42.35
42.76
35.18
23.84
21.77
11.84
Tax Rate
25.39%
25.00%
27.16%
25.97%
25.40%
25.55%
PAT
124.45
128.26
94.34
67.95
63.95
34.50
PAT before Minority Interest
124.45
128.26
94.34
67.95
63.95
34.50
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
9.13%
10.31%
8.72%
7.34%
7.99%
8.40%
PAT Growth
5.17%
35.96%
38.84%
6.25%
85.36%
 
EPS
21.76
22.42
16.49
11.88
11.18
6.03

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
959.42
830.89
276.51
208.61
144.82
Share Capital
57.23
57.23
48.00
12.00
12.00
Total Reserves
902.19
773.67
228.51
196.61
132.82
Non-Current Liabilities
255.75
204.55
194.16
88.09
44.49
Secured Loans
243.55
208.20
62.34
40.36
6.00
Unsecured Loans
0.00
0.00
71.83
26.99
0.00
Long Term Provisions
9.90
9.14
46.82
18.23
36.09
Current Liabilities
376.44
293.98
277.55
315.47
215.15
Trade Payables
201.80
179.66
158.48
144.80
112.23
Other Current Liabilities
77.29
57.98
20.55
28.30
68.96
Short Term Borrowings
65.65
23.84
97.94
120.09
33.43
Short Term Provisions
31.69
32.50
0.58
22.27
0.53
Total Liabilities
1,591.61
1,329.42
748.22
612.17
404.46
Net Block
829.87
357.88
182.88
183.03
79.14
Gross Block
901.14
406.39
215.53
205.97
106.64
Accumulated Depreciation
71.27
48.51
32.65
22.93
27.50
Non Current Assets
865.06
721.17
305.75
212.17
134.01
Capital Work in Progress
22.52
340.79
21.54
0.03
7.26
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
6.82
22.00
101.07
28.82
47.60
Other Non Current Assets
5.85
0.50
0.26
0.28
0.00
Current Assets
719.12
608.25
442.47
400.00
270.46
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
207.99
144.02
117.32
128.39
91.44
Sundry Debtors
331.64
288.49
265.22
212.69
138.55
Cash & Bank
68.17
86.75
18.88
2.44
11.89
Other Current Assets
111.32
8.91
13.45
6.41
28.57
Short Term Loans & Adv.
78.10
80.08
27.61
50.08
26.05
Net Current Assets
342.69
314.27
164.92
84.53
55.31
Total Assets
1,584.18
1,329.42
748.22
612.17
404.47

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 21
Cash From Operating Activity
63.84
146.34
67.12
41.57
PBT
171.02
129.53
91.80
46.34
Adjustment
31.29
37.16
25.92
9.59
Changes in Working Capital
-114.75
7.31
-31.06
-1.14
Cash after chg. in Working capital
87.56
174.00
86.65
54.80
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-23.71
-27.66
-19.53
-13.23
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-151.59
-498.97
-90.84
-19.67
Net Fixed Assets
-171.71
-330.93
-113.42
Net Investments
0.00
0.00
-60.00
Others
20.12
-168.04
82.58
Cash from Financing Activity
91.53
360.83
27.09
-19.34
Net Cash Inflow / Outflow
3.79
8.20
3.37
2.56
Opening Cash & Equivalents
11.73
3.52
0.15
2.23
Closing Cash & Equivalent
15.52
11.73
3.52
4.80

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
167.66
145.20
57.61
43.46
30.17
ROA
8.78%
9.08%
9.99%
12.58%
10.48%
ROE
14.33%
17.04%
28.02%
36.19%
27.04%
ROCE
14.65%
19.06%
24.34%
30.64%
28.42%
Fixed Asset Turnover
1.94
3.48
4.46
5.17
4.09
Receivable days
89.43
93.25
92.78
79.30
100.13
Inventory Days
50.76
44.01
47.70
49.63
69.74
Payable days
108.88
106.52
100.16
88.60
122.96
Cash Conversion Cycle
31.30
30.74
40.32
40.33
46.92
Total Debt/Equity
0.35
0.29
0.85
0.95
0.31
Interest Cover
72.11
7.04
5.60
16.09
12.80

News Update:


  • SMDC completes inspection at Innova Captab’s Jammu facility
    20th Oct 2025, 15:30 PM

    PIC/S certification will play a pivotal role in positioning the newly commissioned Jammu Facility as an international compliant manufacturing site

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.